HT Vista Unveils New Diagnostic Feature for Canine Lump Screening

Jerusalem, 8 May, 2025 (TPS-IL) — HT Vista Ltd. has launched a major update to its AI-driven cancer screening device for dogs, adding a diagnostic capability when specificity exceeds 90%. The update introduces a new scoring system—low, moderate, or high cancer risk—making results easier for veterinarians to interpret and discuss with pet owners.

Built on validated global data, the device achieves a 98% negative predictive value and can now identify specific benign and malignant tumors. HT Vista will showcase the enhanced technology at the upcoming BSAVA Congress 2025 in Rio de Janeiro.